Trial intelligence / Profile preview

Ezetimibe + Simvastatin in Acute Myocardial Infarction

NCT00905905Phase 4Completed

Start
May 2009
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ezetimibe in myocardial infarction (MI) (2 arms). Primary endpoint: C-reactive Protein elevation. Started May 2009; status: completed.

02

Drugs

ezetimibe
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00905905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00905905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call